Table 1.
Demographic and population characteristics of the participants (N = 488).
| Characteristic | Cancer (N = 122) | Healthy (N = 366) | |
|---|---|---|---|
| N (%) or Mean (SD) | N (%) or Mean (SD) | ||
| Female | Gender | 48 (39.3%) | 141 (38.5) NS |
| Male | 74 (60.7%) | 225 (61.5%) | |
| Age | 65.7 (15.1) | 54.6 (10.9) * | |
| No treatment (virgin cancer) | Cancer Treatments | 39 (32.0%) | |
| Had treatment | 83 (68%) | ||
| CLL | Cancer Type | 47 (38.5) | |
| Non-Hodgkin’s lymphoma | 33 (27.0) | ||
| Multiple myeloma | 21 (17.2) | ||
| Hematological malignancies—other | 21 (17.2) | ||
SD—standard deviation; * difference between groups, p < 0.001, NS—difference between groups is non-significant. Hematological malignancies—other (17.2%) included: myelofibrosis (1.6%), acute lymphocytic leukemia (3.3%), acute myeloid leukemia (4.9%), chronic myeloid leukemia (0.8%), and Hodgkin’s lymphoma (4.1%) and unspecified lymphoma (2.5%).